Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We began analyzing https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-015-0066-4, but it redirected us to https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-015-0066-4. The analysis below is for the second page.

Title[redir]:
RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung | Clinical Epigenetics | Full Text
Description:
Background This study was aimed at investigating if the effect of RARβ2 hypermethylation on recurrence-free survival (RFS) in non-small cell lung cancer (NSCLC) depends on one’s smoking status and specific interacting proteins. Results We retrospectively analyzed the expressions of five proteins using immunohistochemistry in archival formalin-fixed and paraffin-embedded tissues from 578 NSCLC patients who had undergone surgical resection from 1994 through 2004. Promoter methylation of RARβ2 was assessed by bisulfite pyrosequencing. Recurrence was found in 268 (46%) of 578 NSCLCs with a median follow-up period of 4.8 years. Overexpression of β-catenin, c-MET, cyclin D1, and EGFR occurred in 55%, 72%, 51%, and 41% of the patients, respectively. E-cadherin expression was negative in 62% of the patients, and RARβ2 hypermethylation was found in 37%. The abnormal expression of c-MET (P = 0.002) and EGFR (P = 0.001) was found to be highly prevalent in never-smokers. RARβ2 hypermethylation was significantly associated with poor recurrence-free survival (RFS) in 128 never-smokers with adenocarcinoma (P = 0.01) For parsimonious model building, the five proteins were clustered into three groups (β-catenin and E-cadherin; c-MET; cyclin D1 and EGFR) by an unsupervised hierarchical clustering and were included in a multivariate analysis. Cox proportional hazard analysis showed that RARβ2 hypermethylation was significantly associated with poor RFS in 128 never-smokers with adenocarcinoma (adjusted hazard ratio [HR] = 2.19, 95% confidence interval [CI] = 1.28 to 3.47; P = 0.009), after adjusting for interacting proteins. Conclusions The present study suggests that RARβ2 hypermethylation may be an independent prognostic factor of RFS in never-smokers with adenocarcinoma of the lung.

Matching Content Categories {📚}

  • Science
  • Education
  • Fitness & Wellness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🚄 Respectable Traffic: 10k - 20k visitors per month


Based on our best estimate, this website will receive around 10,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

rarβ, cancer, expression, neversmokers, hypermethylation, proteins, lung, rfs, adenocarcinoma, article, google, scholar, egfr, levels, pubmed, cyclin, cells, cell, acid, methylation, recurrence, βcatenin, retinoic, cas, effect, tissues, patients, figure, study, analyzed, ecadherin, analysis, cmet, nsclc, found, kim, lee, tumor, staining, data, survival, eversmokers, status, growth, compared, test, poor, smoking, showed, factor,

Topics {✒️}

formalin-fixed paraffin-embedded tissue beta-catenin/lef-tcf pathway node-negative stage i-ii 578 formalin-fixed paraffin-embedded kaplan-meier survival curves kaplan-meier survival curve reduce inter-observer variability randomized placebo-controlled trial methods study population full size image duk-hwan kim eun yoon cho wilcoxon rank-sum test poor inter-rater reliability methylation-specific pcr technique 10-μm-thick sections state privacy rights lung cancer-derived cells small-cell lung cancer quantitative reverse transcription-pcr beta-catenin protein stability bo bin lee abbreviations rfs e-cadherin/catenin complex real-time pcr poor recurrence-free survival β-catenin-lef/tcf privacy choices/manage cookies paraffin-embedded tissues archival formalin-fixed cut formalin-fixed authors scientific editing bmc β-catenin/tcf signaling [13] prospective large-scale studies wnt/β-catenin signaling south san francisco nuclear β-catenin interacts national research foundation springer nature ubiquitin-proteasome pathway [17] smoker cancer-related death small sample size samsung medical center pyromark pcr kit 9-cis-retinoic acid [9] 9-cis-retinoic acid post-operative follow breast cancer cells

Questions {❓}

  • Is it reasonable to recommend the intake of retinoids for the chemoprevention of recurrence in never-smokers who have undergone surgical resection for NSCLC?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
         description:This study was aimed at investigating if the effect of RARβ2 hypermethylation on recurrence-free survival (RFS) in non-small cell lung cancer (NSCLC) depends on one’s smoking status and specific interacting proteins. We retrospectively analyzed the expressions of five proteins using immunohistochemistry in archival formalin-fixed and paraffin-embedded tissues from 578 NSCLC patients who had undergone surgical resection from 1994 through 2004. Promoter methylation of RARβ2 was assessed by bisulfite pyrosequencing. Recurrence was found in 268 (46%) of 578 NSCLCs with a median follow-up period of 4.8 years. Overexpression of β-catenin, c-MET, cyclin D1, and EGFR occurred in 55%, 72%, 51%, and 41% of the patients, respectively. E-cadherin expression was negative in 62% of the patients, and RARβ2 hypermethylation was found in 37%. The abnormal expression of c-MET (P = 0.002) and EGFR (P = 0.001) was found to be highly prevalent in never-smokers. RARβ2 hypermethylation was significantly associated with poor recurrence-free survival (RFS) in 128 never-smokers with adenocarcinoma (P = 0.01) For parsimonious model building, the five proteins were clustered into three groups (β-catenin and E-cadherin; c-MET; cyclin D1 and EGFR) by an unsupervised hierarchical clustering and were included in a multivariate analysis. Cox proportional hazard analysis showed that RARβ2 hypermethylation was significantly associated with poor RFS in 128 never-smokers with adenocarcinoma (adjusted hazard ratio [HR] = 2.19, 95% confidence interval [CI] = 1.28 to 3.47; P = 0.009), after adjusting for interacting proteins. The present study suggests that RARβ2 hypermethylation may be an independent prognostic factor of RFS in never-smokers with adenocarcinoma of the lung.
         datePublished:2015-03-19T00:00:00Z
         dateModified:2015-03-19T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13148-015-0066-4
         keywords:
            Lung cancer
            RARβ2
            Methylation
            Never-smoker
            Recurrence
            Human Genetics
            Gene Function
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig4_HTML.gif
         isPartOf:
            name:Clinical Epigenetics
            issn:
               1868-7083
               1868-7075
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yujin Kim
               affiliation:
                     name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:DongHao Jin
               affiliation:
                     name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bo Bin Lee
               affiliation:
                     name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eun Yoon Cho
               affiliation:
                     name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joungho Han
               affiliation:
                     name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Young Mog Shim
               affiliation:
                     name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Duk-Hwan Kim
               affiliation:
                     name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                        type:PostalAddress
                     type:Organization
                     name:Samsung Biomedical Research Institute
                     address:
                        name:Samsung Biomedical Research Institute, Kangnam-Ku, South Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
      description:This study was aimed at investigating if the effect of RARβ2 hypermethylation on recurrence-free survival (RFS) in non-small cell lung cancer (NSCLC) depends on one’s smoking status and specific interacting proteins. We retrospectively analyzed the expressions of five proteins using immunohistochemistry in archival formalin-fixed and paraffin-embedded tissues from 578 NSCLC patients who had undergone surgical resection from 1994 through 2004. Promoter methylation of RARβ2 was assessed by bisulfite pyrosequencing. Recurrence was found in 268 (46%) of 578 NSCLCs with a median follow-up period of 4.8 years. Overexpression of β-catenin, c-MET, cyclin D1, and EGFR occurred in 55%, 72%, 51%, and 41% of the patients, respectively. E-cadherin expression was negative in 62% of the patients, and RARβ2 hypermethylation was found in 37%. The abnormal expression of c-MET (P = 0.002) and EGFR (P = 0.001) was found to be highly prevalent in never-smokers. RARβ2 hypermethylation was significantly associated with poor recurrence-free survival (RFS) in 128 never-smokers with adenocarcinoma (P = 0.01) For parsimonious model building, the five proteins were clustered into three groups (β-catenin and E-cadherin; c-MET; cyclin D1 and EGFR) by an unsupervised hierarchical clustering and were included in a multivariate analysis. Cox proportional hazard analysis showed that RARβ2 hypermethylation was significantly associated with poor RFS in 128 never-smokers with adenocarcinoma (adjusted hazard ratio [HR] = 2.19, 95% confidence interval [CI] = 1.28 to 3.47; P = 0.009), after adjusting for interacting proteins. The present study suggests that RARβ2 hypermethylation may be an independent prognostic factor of RFS in never-smokers with adenocarcinoma of the lung.
      datePublished:2015-03-19T00:00:00Z
      dateModified:2015-03-19T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13148-015-0066-4
      keywords:
         Lung cancer
         RARβ2
         Methylation
         Never-smoker
         Recurrence
         Human Genetics
         Gene Function
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13148-015-0066-4/MediaObjects/13148_2015_66_Fig4_HTML.gif
      isPartOf:
         name:Clinical Epigenetics
         issn:
            1868-7083
            1868-7075
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yujin Kim
            affiliation:
                  name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:DongHao Jin
            affiliation:
                  name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bo Bin Lee
            affiliation:
                  name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eun Yoon Cho
            affiliation:
                  name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joungho Han
            affiliation:
                  name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Young Mog Shim
            affiliation:
                  name:Samsung Medical Center, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Duk-Hwan Kim
            affiliation:
                  name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
                     type:PostalAddress
                  type:Organization
                  name:Samsung Biomedical Research Institute
                  address:
                     name:Samsung Biomedical Research Institute, Kangnam-Ku, South Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Clinical Epigenetics
      issn:
         1868-7083
         1868-7075
      volumeNumber:7
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
      address:
         name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
         type:PostalAddress
      name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
      address:
         name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
         type:PostalAddress
      name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
      address:
         name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
         type:PostalAddress
      name:Samsung Medical Center, Sungkyunkwan University School of Medicine
      address:
         name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
         type:PostalAddress
      name:Samsung Medical Center, Sungkyunkwan University School of Medicine
      address:
         name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
         type:PostalAddress
      name:Samsung Medical Center, Sungkyunkwan University School of Medicine
      address:
         name:Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
         type:PostalAddress
      name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
      address:
         name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
         type:PostalAddress
      name:Samsung Biomedical Research Institute
      address:
         name:Samsung Biomedical Research Institute, Kangnam-Ku, South Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yujin Kim
      affiliation:
            name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
            address:
               name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
               type:PostalAddress
            type:Organization
      name:DongHao Jin
      affiliation:
            name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
            address:
               name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
               type:PostalAddress
            type:Organization
      name:Bo Bin Lee
      affiliation:
            name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
            address:
               name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
               type:PostalAddress
            type:Organization
      name:Eun Yoon Cho
      affiliation:
            name:Samsung Medical Center, Sungkyunkwan University School of Medicine
            address:
               name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
               type:PostalAddress
            type:Organization
      name:Joungho Han
      affiliation:
            name:Samsung Medical Center, Sungkyunkwan University School of Medicine
            address:
               name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
               type:PostalAddress
            type:Organization
      name:Young Mog Shim
      affiliation:
            name:Samsung Medical Center, Sungkyunkwan University School of Medicine
            address:
               name:Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
               type:PostalAddress
            type:Organization
      name:Duk-Hwan Kim
      affiliation:
            name:Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine
            address:
               name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
               type:PostalAddress
            type:Organization
            name:Samsung Biomedical Research Institute
            address:
               name:Samsung Biomedical Research Institute, Kangnam-Ku, South Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
      name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
      name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
      name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
      name:Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
      name:Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, South Korea
      name:Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Kyunggido, South Korea
      name:Samsung Biomedical Research Institute, Kangnam-Ku, South Korea

External Links {🔗}(236)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

3.65s.